Barry J. Kappel, Ph.D.
Affiliations: | 2006 | Weill Cornell Medical College, New York, NY, United States |
Area:
Immunology, Pharmacology, PathologyGoogle:
"Barry Kappel"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| David A. Scheinberg | grad student | 2006 | Weill Cornell Medical College | |
| (Depletion of specific immunity: A novel use of recombinant MHC molecules.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Rotolo JA, Ramirez R, Koester M, et al. (2019) Abstract 2050: Cell penetrating peptide, ST101, disrupts ATF5 regulation of anti-apoptotic Bcl-2 family proteins, resulting in induction of cancer cell death in vitro and tumor growth inhibition/regression in vivo Cancer Research. 79: 2050-2050 |
| Sofou S, Enmon R, Palm S, et al. (2010) Large anti-HER2/neu liposomes for potential targeted intraperitoneal therapy of micrometastatic cancer. Journal of Liposome Research. 20: 330-40 |
| Sofou S, Kappel BJ, Jaggi JS, et al. (2007) Enhanced retention of the α-particle-emitting daughters of actinium-225 by liposome carriers Bioconjugate Chemistry. 18: 2061-2067 |
| Jaggi JS, Carrasquillo JA, Seshan SV, et al. (2007) Improved tumor imaging and therapy via i.v. IgG-mediated time-sequential modulation of neonatal Fc receptor. The Journal of Clinical Investigation. 117: 2422-30 |
| McDevitt MR, Chattopadhyay D, Kappel BJ, et al. (2007) Tumor targeting with antibody-functionalized, radiolabeled carbon nanotubes. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 48: 1180-9 |
| Singh Jaggi J, Henke E, Seshan SV, et al. (2007) Selective alpha-particle mediated depletion of tumor vasculature with vascular normalization Plos One. 2 |
| Jaggi JS, Carrasquillo JA, Seshan SV, et al. (2007) Erratum: Improved tumor imaging and therapy via i.v. IgG-mediated time-sequential modulation of neonatal Fc receptor (Journal of Clinical Investigation (2007) 117, (2422-2430) DOI: 10.1172/JCI32226)) Journal of Clinical Investigation. 117 |
| Pinilla-Ibarz J, May RJ, Korontsvit T, et al. (2006) Improved human T-cell responses against synthetic HLA-0201 analog peptides derived from the WT1 oncoprotein Leukemia. 20: 2025-2033 |
| Kappel BJ, Pinilla-Ibarz J, Kochman AA, et al. (2006) Remodeling specific immunity by use of MHC tetramers: demonstration in a graft-versus-host disease model. Blood. 107: 2045-51 |
| Dao T, Gomez-Nunez M, Antczak C, et al. (2005) Natural killer cells license dendritic cell cross-presentation of B lymphoma cell--associated antigens. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 8763-72 |